FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

GALLAGHER JOHN J III 		2. Issuer Name and Ticker or Trading Symbol

Celanese CORP [ CE ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
EVP & President, Acetyls
(Last)          (First)          (Middle)

C/O CELANESE CORPORATION, 1601 W. LBJ FREEWAY 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/12/2007
(Street)

DALLAS, TX 75234
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Series A Common Stock   12/12/2007     M    200000   A $18.30   237000   D    
Series A Common Stock   12/12/2007     S    15700   D $42.50   221300   D    
Series A Common Stock   12/12/2007     S    6000   D $42.51   215300   D    
Series A Common Stock   12/12/2007     S    4000   D $42.52   211300   D    
Series A Common Stock   12/12/2007     S    4000   D $42.53   207300   D    
Series A Common Stock   12/12/2007     S    1800   D $42.54   205500   D    
Series A Common Stock   12/12/2007     S    4300   D $42.55   201200   D    
Series A Common Stock   12/12/2007     S    3900   D $42.56   197300   D    
Series A Common Stock   12/12/2007     S    5300   D $42.57   192000   D    
Series A Common Stock   12/12/2007     S    3400   D $42.58   188600   D    
Series A Common Stock   12/12/2007     S    4400   D $42.59   184200   D    
Series A Common Stock   12/12/2007     S    3200   D $42.60   181000   D    
Series A Common Stock   12/12/2007     S    4900   D $42.61   176100   D    
Series A Common Stock   12/12/2007     S    3000   D $42.62   173100   D    
Series A Common Stock   12/12/2007     S    2700   D $42.63   170400   D    
Series A Common Stock   12/12/2007     S    1000   D $42.64   169400   D    
Series A Common Stock   12/12/2007     S    8400   D $42.65   161000   D    
Series A Common Stock   12/12/2007     S    4287   D $42.66   146713   D    
Series A Common Stock   12/12/2007     S    4913   D $42.67   151800   D    
Series A Common Stock   12/12/2007     S    2400   D $42.68   149400   D    
Series A Common Stock   12/12/2007     S    1100   D $42.69   148300   D    
Series A Common Stock   12/12/2007     S    8400   D $42.70   139900   D    
Series A Common Stock   12/12/2007     S    7400   D $42.71   132500   D    
Series A Common Stock   12/12/2007     S    3800   D $42.72   128700   D    
Series A Common Stock   12/12/2007     S    5100   D $42.73   123600   D    
Series A Common Stock   12/12/2007     S    7700   D $42.74   115900   D    
Series A Common Stock   12/12/2007     S    5600   D $42.75   110300   D    
Series A Common Stock   12/12/2007     S    13250   D $42.76   97050   D    
Series A Common Stock   12/12/2007     S    8300   D $42.77   88750   D    
Series A Common Stock   12/12/2007     S    3000   D $42.78   85750   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)   $18.30   12/12/2007     M        100000      (1) 8/31/2015   Series A Common Stock   100000   $0   192000   D    
Non-Qualified Stock Option (Right to Buy)   $18.30   12/12/2007     M        100000      (2) 8/31/2015   Series A Common Stock   100000   $0   338000   D    

Explanation of Responses:
(1)  Granted pursuant to the Company's 2004 Stock Incentive Plan. The options vest with respect to 20% on each of December 31, 2005 and December 31, 2006, and subject to continued employment, will vest with respect to 20% on each of December 31, 2007, December 31, 2008, and March 31, 2009.
(2)  Granted pursuant to the Company's 2004 Stock Incentive Plan. The options vest with respect to 15% of the options on December 31, 2005, with respect to 30% of the options on December 31, 2006, and subject to continued employment and achievement of certain performance targets, will vest with respect to 30% of the options on December 31, 2007, and with respect to 25% of the option shares on December 31, 2008, and (ii) will vest 100%, in any event, regardless of the achievement of certain performance targets, no later than August 31, 2013.

Remarks:
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2007.



This is Part One of a Form 4 filed by the reporting person. The Form 4 was filed in three parts due to the restrictions in the electronic filing process.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
GALLAGHER JOHN J III
C/O CELANESE CORPORATION
1601 W. LBJ FREEWAY
DALLAS, TX 75234

EVP & President, Acetyls

Signatures
/s/ Suzanne L. Kersten, Attorney-in-Fact for John J. Gallagher III 12/14/2007
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.